Author

Shitalben Patel

AbbVie (United States)ORCID 0000-0003-3710-0497Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

James E. KathiD· 2 shared Adam Banlasan· 1 shared Christina K. BaumgartneriD· 1 shared Frank Gambino· 1 shared Gregory K. PottsiD· 1 shared Helena Costa· 1 shared Hua Tang· 1 shared Hui JingiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

James E. KathORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryJournal of Proteome ResearchPeer-reviewedJan 27, 2025

An Automated High-throughput Affinity Capture-Mass Spectrometry Platform with Data-Independent Acquisition

Hui Jing, Paul L. Richardson, Gregory K. Potts…·Jon D. Williams

This paper describes an automated AC-MS platform with DIA-MS for efficient kinase profiling and inhibitor selectivity assessment.

4 citations

proteomicsexperimental assay

𝕏 PostBluesky

Molecular BiologySLAS DISCOVERYPeer-reviewedDec 13, 2023

Quantitative target engagement of RIPK1 in human whole blood via the cellular thermal shift assay for potential pre-clinical and clinical applications

Shitalben Patel, Marie Karlsson, Joseph T. Klahn…·James E. Kath

This paper develops quantitative CETSA(R) methods in unprocessed human whole blood for measuring target engagement of RIPK1 inhibitors, showing high sensitivity and robustness.

1 citation

humanexperimental assay

𝕏 PostBluesky